227017-88-1 Usage
General Description
N-(3,4-dimethoxybenzyl)cyclohexanamine, also known as DME, is a chemical compound with the formula C17H23NO2. It is a derivative of cyclohexanamine and contains a benzyl group with two methoxy (CH3O-) substituents on the 3 and 4 positions. DME is commonly used as a building block in organic synthesis, particularly in the pharmaceutical industry for the synthesis of various drugs and pharmaceuticals. It has also been studied for its potential therapeutic applications, including its role as a potential anti-inflammatory and analgesic agent. Additionally, research has been conducted on the pharmacological effects of DME in the central nervous system, including its potential as a treatment for neurological disorders. Overall, N-(3,4-dimethoxybenzyl)cyclohexanamine is a versatile chemical compound with potential applications in various industries and research fields.
Check Digit Verification of cas no
The CAS Registry Mumber 227017-88-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,7,0,1 and 7 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 227017-88:
(8*2)+(7*2)+(6*7)+(5*0)+(4*1)+(3*7)+(2*8)+(1*8)=121
121 % 10 = 1
So 227017-88-1 is a valid CAS Registry Number.
InChI:InChI=1/C15H23NO2/c1-17-14-9-8-12(10-15(14)18-2)11-16-13-6-4-3-5-7-13/h8-10,13,16H,3-7,11H2,1-2H3
227017-88-1Relevant articles and documents
ANTI-DIABETIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND METHOD TO TREAT DIABETES
-
Page/Page column 22, (2015/11/10)
Described are compounds of Formula I as well as anti-hyperglycemic pharmaceutical compositions containing one or more of these compounds, and method to treat diabetes using the compounds and/or compositions. Also disclosed herein is a pharmaceutical compo
